Patient Guide: Study of GS-0272 in Participants With Rheumatoid Arthritis

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 22 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT06031415
Status: 🟢 Enrolling Now
Condition: Rheumatoid Arthritis
Phase: PHASE1

Where You Can Participate

This study is available at 22 locations across the country.

Top locations include:
  • • Glendale, California
  • • Palo Alto, California
  • • Upland, California
  • • And 19 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

Study of GS-0272 in Participants With Rheumatoid Arthritis - Join Clinical Trial NCTNCT06031415

How to Join This Clinical Trial - NCTNCT06031415

Learn how to participate in this PHASE1 trial studying an investigational therapy for Rheumatoid Arthritis. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Rheumatoid Arthritis. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Rheumatoid Arthritis
Treatment Being Tested
Investigational treatment
Study Phase
PHASE1 - Early safety study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT06031415 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 22 locations. Find a study site near you:

Clinical Research Site

Glendale, California 85306 - United States

Status: RECRUITING

Clinical Research Site

Palo Alto, California 94304 - United States

Status: RECRUITING

Clinical Research Site

Upland, California 91786 - United States

Status: RECRUITING

Clinical Research Site

Clearwater, Florida 33765 - United States

Status: RECRUITING

Clinical Research Site

Jacksonville, Florida 32216 - United States

Status: RECRUITING

Clinical Research Site

Niles, Illinois 60714 - United States

Status: RECRUITING

Clinical Research Site

Schaumburg, Illinois 60195 - United States

Status: RECRUITING

Clinical Research Site

Portland, Oregon 97210 - United States

Status: RECRUITING

Clinical Research Site

Duncansville, Pennsylvania 16635 - United States

Status: COMPLETED

Clinical Research Site

Wyomissing, Pennsylvania 19610 - United States

Status: RECRUITING

And 12 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE1 clinical trial for Rheumatoid Arthritis:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships